Science Explorer Back to mapMap

Most cited papers from Avanir Pharmaceuticals (United States)

What are the most cited papers from Avanir Pharmaceuticals (United States)?

The most cited paper from Avanir Pharmaceuticals (United States) is "Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect" (Erik P. Pioro, Benjamin Rix Brooks, Jeffrey L. Cummings et al., 2010), with 372 citations. Next come "Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients" (215) and "Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia" (208).

Showing 50 of 61 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect Erik P. Pioro, Benjamin Rix Brooks, Jeffrey L. Cummings et al. · Annals of Neurology 13 Sep 2010 372
2 Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients Raymond T. Bartus, Tiffany L. Baumann, Joao O. Siffert et al. · Neurology Open access 11 Apr 2013 215
3 Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia Jeffrey L. Cummings, Constantine G. Lyketsos, Elaine R. Peskind et al. · JAMA 22 Sep 2015 208
4 Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use Charles P. Taylor, Stephen F. Traynelis, Joao O. Siffert et al. · Pharmacology & Therapeutics Open access May 2016 188
5 Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis HILLEL S. PANITCH, Ronald A. Thisted, Richard Alan Smith et al. · Annals of Neurology 21 Apr 2006 176
6 INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY Raj K. Maturi, Ayala Pollack, Harvey Siy Uy et al. · Retina Open access 12 Feb 2016 130
7 Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers Laura E. Pope, M.H. Khalil, James E. Berg et al. · The Journal of Clinical Pharmacology Sep 2004 125
8 The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions Christopher K. Cote, Cynthia A. Rossi, Angray S. Kang et al. · Microbial Pathogenesis 24 Apr 2005 124
9 Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. David H. Katz, John F. Marcelletti, Mina Khalil et al. · Proceedings of the National Academy of Sciences Open access Dec 1991 108
10 Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology Jesse Mez et al. · Alzheimer s & Dementia Open access 7 Apr 2021 107
11 Pseudobulbar affect: an under-recognized and under-treated neurological disorder Susan S. Work, Jennifer Colamonico, Walter G. Bradley et al. · Advances in Therapy Open access 6 Jun 2011 105
12 Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients Richard Alan Smith, James E. Berg, Laura E. Pope et al. · Multiple Sclerosis Journal 13 Nov 2004 101
13 Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed Ritsuko Sawada-Hirai, Ivy Jiang, Fei Wang et al. · Journal of Immune Based Therapies and Vaccines Open access 12 May 2004 98
14 The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process Laura E. Pope, John F. Marcelletti, Lee R. Katz et al. · Antiviral Research Dec 1998 95
15 Human Monoclonal Anti-Protective Antigen Antibody Completely Protects Rabbits and Is Synergistic with Ciprofloxacin in Protecting Mice and Guinea Pigs against Inhalation Anthrax Johnny Wayne Peterson, Jason E. Comer, David M. Noffsinger et al. · Infection and Immunity Open access 21 Jan 2006 81
16 The urinary safety profile and secondary renal effects of retigabine (ezogabine): A first‐in‐class antiepileptic drug that targets KCNQ (Kv7) potassium channels Neil Brickel, Paul Gandhi, Kevan VanLandingham et al. · Epilepsia 16 Mar 2012 75
17 PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions Benjamin Rix Brooks, David W. Crumpacker, Jonathan L. Fellus et al. · PLoS ONE Open access 21 Aug 2013 74
18 Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study for the Ozurdex MEAD Study Group, Albert J. Augustin, Baruch D. Kuppermann et al. · BMC Ophthalmology Open access 30 Oct 2015 72
19 Pseudobulbar Affect: Burden of Illness in the USA Jennifer Colamonico, Andrea E. Formella, Walter G. Bradley · Advances in Therapy Open access 30 Aug 2012 69
20 Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit Model Johnny Wayne Peterson, Jason E. Comer, Wallace B. Baze et al. · Infection and Immunity Open access 24 Apr 2007 58
21 AVP ‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks Stewart J. Tepper, Roger K. Cady, Stephen David Silberstein et al. · Headache The Journal of Head and Face Pain Open access May 2015 56
22 Novel 2-(Substituted phenyl)benzimidazole Derivatives with Potent Activity against IgE, Cytokines, and CD23 for the Treatment of Allergy and Asthma Mark L. Richards, Shirley Cruz Lio, Anjana Sinha et al. · Journal of Medicinal Chemistry 13 Nov 2004 51
23 Efficacy and Safety of Dextromethorphan/Quinidine at Two Dosage Levels for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study Aziz I. Shaibani, Laura E. Pope, Ronald A. Thisted et al. · Pain Medicine Open access Feb 2012 50
24 Thermodynamics of Fatty Acid Binding to Engineered Mutants of the Adipocyte and Intestinal Fatty Acid-binding Proteins Gary V. Richieri, Pamela J. Low, Ronald T. Ogata et al. · Journal of Biological Chemistry Open access Mar 1998 49
25 Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug Laura E. Pope, John F. Marcelletti, Lee R. Katz et al. · Journal of Lipid Research Open access Oct 1996 40
26 PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury Flora McConnell Hammond, David N. Alexander, Andrew J. Cutler et al. · BMC Neurology Open access 4 Jun 2016 37
27 An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions Gary L. Pattee, James P. Wymer, Catherine Lomen‐Hoerth et al. · Current Medical Research and Opinion Open access 25 Jul 2014 37
28 Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease Susan Helen Fox, Leonard Verhagen Metman, John G. Nutt et al. · Movement Disorders 30 Mar 2017 35
29 2-Phenylimidazopyridines, a New Series of Golgi Compounds with Potent Antiviral Activity Homayon Banie, Anjana Sinha, Richard J. Thomas et al. · Journal of Medicinal Chemistry 31 Oct 2007 34
30 Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma Malcolm S. Mitchell, June Kan‐Mitchell, Philip R. Morrow et al. · Clinical Cancer Research 2004 33
31 Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-Label, dose-escalation study Ronald A. Thisted, Leslie J. Klaff, Sherwyn Leon Schwartz et al. · Clinical Therapeutics Oct 2006 33
32 Substituted 2-phenyl-benzimidazole derivatives: novel compounds that suppress key markers of allergy Mark L. Richards, Shirley Cruz Lio, Anjana Sinha et al. · European Journal of Medicinal Chemistry 5 May 2006 32
33 Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs John F. Marcelletti · Antiviral Research 7 Oct 2002 32
34 Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly Fei Wang, Paul E. Ruther, Ivy Jiang et al. · Human Antibodies 22 Jan 2005 31
35 n‐Docosanol: Broad Spectrum Anti‐Viral Activity against Lipid‐enveloped Virusesa David H. Katz, JOHN R. MARCELLETTI, Laura E. Pope et al. · Annals of the New York Academy of Sciences May 1994 28
36 Topical application of docosanol‐ or stearic acid‐containing creams reduces severity of phenol burn wounds in mice Mohammed Khalil, John F. Marcelletti, Lee R. Katz et al. · Contact Dermatitis Aug 2000 27
37 Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP‐825 Breath Powered ® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan Stephen David Silberstein, Paul K Winner, Peter J. McAllister et al. · Headache The Journal of Head and Face Pain 11 May 2017 26
38 Measuring pseudobulbar affect in ALS Richard Alan Smith, James E. Berg, Laura E. Pope et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Sep 2004 26
39 Results From a 2-Year Centralized Tolcapone Liver Enzyme Monitoring Program Mark Lew, Greg Kricorian · Clinical Neuropharmacology Sep 2007 24
40 Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor. Jonathan A. Chappel, William O. Rogers, Stephen L. Hoffman et al. · Malaria Journal Open access 2004 23
41 Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers Kerri A. Schoedel, Laura E. Pope, Edward M. Sellers · Clinical Drug Investigation 31 Jan 2012 23
42 Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM‐II Open Label Study Flora McConnell Hammond, William M. Sauvé, Fred Ledon et al. · PM&R Open access 23 Feb 2018 22
43 Faster Improvement in Migraine Pain Intensity and Migraine‐Related Disability at Early Time Points with AVP‐825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study Richard B. Lipton, James S. McGinley, Kenneth J. Shulman et al. · Headache The Journal of Head and Face Pain 7 Sep 2017 19
44 The Antiviral Drug Docosanol as a Treatment for Kaposi's Sarcoma Lesions in HIV Type 1-Infected Patients: A Pilot Clinical Study Michael J. Scolaro, Lucy B. Gunnill, Laura E. Pope et al. · AIDS Research and Human Retroviruses 2001 19
45 Oxymetazoline and Energy‐Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open‐Label, Interventional Study Emil A Tanghetti, David J. Goldberg, Jeffrey S. Dover et al. · Lasers in Surgery and Medicine Open access 6 May 2020 18
46 PROGRESS IN TREATMENT DEVELOPMENT FOR NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE: FOCUS ON AGITATION AND AGGRESSION. A REPORT FROM THE EU/US/CTAD TASK FORCE Maria‐Eugenia Soto, Susan R. Abushakra, Jeffrey L. Cummings et al. · The Journal of Prevention of Alzheimer s Disease Open access 2015 17
47 PRISM: A Novel Tool to Prospectively Estimate the Prevalence of Pseudobulbar Affect Symptoms David W. Crumpacker, Jonathan L. Fellus, Daniel Kantor et al. · American Journal of Geriatric Psychiatry Open access Mar 2013 17
48 IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response John F. Marcelletti · The Journal of Immunology Oct 1996 16
49 AVP‐825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial Richard B. Lipton, James S. McGinley, Kenneth J. Shulman et al. · Headache The Journal of Head and Face Pain 16 Oct 2017 15
50 Effects of stress on functional connectivity during verbal processing Neetu Nair, John P. Hegarty, Bradley J. Ferguson et al. · Brain Imaging and Behavior 12 Dec 2019 14

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.